Samvardhana Motherson International Ltd
MOTHERSONSamvardhana Motherson International Ltd's price has outrun its earnings. +57.1% in a year against EPS +1.7% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +57.1% in a year while annual EPS moved +1.7% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (49 weeks in) while the P/E sits at the 67th percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +77.6% year on year, and 223% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Samvardhana Motherson International Ltd trades at ₹164, in a confirmed uptrend and 49 weeks into that stage. That is +20.3% against its own 200-day average. It sits at 92% of a 52-week range of ₹104 to ₹169. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 7 straight weeks.
Today the stock is in a confirmed uptrend — week 49 of stage 2, confirmed. At ₹164 it trades +20.3% versus its 200-day average and sits at 92% of its 52-week range (₹104–₹169).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +361% while the NIFTY 500 moved +273% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 7 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
Samvardhana Motherson International Ltd's story is not scored yet against the markers our research file set on 22 August 2026. Where it sits in its own cycle: Not stated in the research file. Our fortnightly research layers last read it on 22 August 2026.
Our read, 22 August 2026. Motherson delivered its strongest-ever quarterly revenue in Q1 FY27 and confirmed aerospace and CE as live growth engines — but OPM mean-reversion has begun, the PE has expanded to the 67.5th percentile, and CE order visibility softened in the August call, so the bull case now depends on GF3 delivery and non-auto margin mix arriving before the auto cycle fully reverts.
What is proven. Motherson delivered its strongest-ever quarterly revenue in Q1 FY27 and confirmed aerospace and CE as live growth engines — but OPM mean-reversion has begun, the PE has expanded to the 67.5th percentile, and CE order visibility softened in the August call, so the bull case now depends on GF3 delivery and non-auto margin mix arriving before the auto cycle fully reverts.
🚨 What would change our mind. If consumer electronics Q3 FY27 commissioning is confirmed AND GF3 orders crystallize into disclosed revenue commitments at or above the prior 'fully spoken for' level, the CE risk resolves and the growth-minus-margin-drag equation shifts positively. Conversely, if auto OPM prints below 8.5% for two consecutive quarters while non-auto EBITDA remains below 12% of the consolidated total, the PEAK_MARGIN_VALUE_TRAP has fully arrived without the offsetting scale, and the current PE of 39.1x is…
🚨 Layer 1 read, 22 August 2026 — DROP. Two years of 22% revenue growth produced no extra profit — the shares re-rated anyway, and that gap is the whole risk. Set the June 2026 quarter beside the same quarter two years earlier instead of last year's weak one: revenue Rs 35,244 Cr against Rs 28,868 Cr, but pre-tax profit only Rs 1,533 Cr against Rs 1,445 Cr and net profit slightly LOWER, Rs 1,076 Cr against Rs 1,097 Cr. The reason is margin: it hit an eleven-year high of 11.05% last March and has fallen back to 8.79%, which the Timeline states is confirmed mean reversion to the 8.7% long-run normal. Over the same stretch the share rating expanded roughly 31% and the price sits at its all-time high — buyers paid more for earnings that stood still. There is a real business underneath: aerospace revenue is up over 20% with the order book 17% bigger…
What would change Layer 1’s mind. The Timeline's own break condition is margin below 8.5% for two consecutive quarters while non-auto earnings stay under 12% of the total, and its GF3 driver kill-switch is orders failing to firm up before commissioning. Sharpened to this verdict: if the September 2026 quarter shows operating margin at or above 9.0% AND the November call confirms GF3 orders back at committed-load level, the flat-profit finding becomes a one-off trough and this goes to P1. The reverse — margin below 8.5% with GF3…
🚨 What the surface reading misses. The surface reading is: OPM at 11.05% — margins improving, positive for earnings trajectory The research reads it further: The 10-year OPM band runs from approximately -7.4% to 11.05%. At the 98th percentile, the margin is at the top of its own history. GPM has been relatively stable — the OPM improvement came from opex leverage and mix, not gross profit expansion. This is operating leverage at peak, not structural margin re-rating.
🚨 What the surface reading misses. The surface reading is: PE of 39.1x at 67.5th percentile — within historical range but above median of 33.6x The research reads it further: The PE has expanded from 35.7x to 39.1x while TTM earnings grew from Rs 4086 Cr to Rs 4556 Cr (+11.5%). The multiple itself expanded from 53.8th to 67.5th percentile. This simultaneous PE expansion and OPM reversion creates a worsening risk: more expensive on reverting earnings.
Sources: our stock research file (22 August 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Samvardhana Motherson International Ltd reported ₹35,244 Cr of revenue in the Jun 26 quarter, +16.7% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 13.0% a year. The last full year, FY26, came in at ₹1,26,104 Cr. The last four reported quarters add to ₹1,31,135 Cr.
Why this happened. Consumer electronics EBITDA turned positive in FY26 with 7.5x YoY revenue growth. GF1 and GF2 operate near full utilization at approximately 14-16 million units annually. GF3 — the largest facility yet — remains on track for Q3 FY27 commissioning per August 2026 guidance. However, August management described orders as 'under negotiation' whereas the May 2026 call said the plant was 'fully already spoken for'. Management explained CE does not have long order tails — orders happen closer to the selling season. This is a plausible explanation but reduces visibility confidence materially from what was implied in May. The next unit economics confirmation is expected when GF3 approaches full…
FY26 revenue came in at ₹1,26,104 Cr (+10.9% on the year), capping 10 years at 13.0% compound. The latest quarter (Jun 26) printed ₹35,244 Cr, +16.7% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +13.9% growth against the decade's 13.0% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +14.0% over the last 4 quarters against +11.7%/yr over the last 8 — stabilising; TTM profit +24.7% vs +14.6%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Samvardhana Motherson International Ltd's operating margin is 9.0% in the Jun 26 quarter, +1.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the operating margin has ranged 7.0% to 10.0%. The current quarter sits inside that band.
Why this happened. The Molds and Polymer restructuring — launched targeting EUR 50 million savings — has now delivered measurable margin improvement. Q4 FY26 EBITDA margins expanded 200 basis points YoY, with European polymer up 55% YoY and 66% QoQ in the Aug-26 call on restructuring benefits. Consolidated underutilized facilities and headcount reductions completed. New EV launches receive better customer response, and rebalanced sites retain capacity headroom for the next volume cycle. Old low-margin programs are phasing out as new programs at better pricing launch.
The latest quarter's operating margin is 9.0%, +1.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 7.0%–10.0%, and FY26's 10.0% is the top of that band — a record year.
Why the margin moved: operating margin went +0.6 pp year on year while gross margin went −0.9 pp — the gain came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Samvardhana Motherson International Ltd earned ₹1,076 Cr of net profit in the Jun 26 quarter, +77.6% year on year. It is the 3rd consecutive quarter of growth. Full-year FY26 profit was ₹4,086 Cr. The 10-year compound rate is 8.7%. That is 3.1% of the quarter's revenue. The same quarter a year earlier earned ₹606 Cr.
Jun 26 profit was ₹1,076 Cr, +77.6% year on year — the 3rd consecutive quarter of growth. On the full year, FY26 printed ₹4,086 Cr (−1.4%), and the 10-year compound rate is 8.7%.
Why profit moved: revenue contributed +16.7% and the margin +1.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +28.9% vs revenue +13.9%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 223% of Samvardhana Motherson International Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹11,284 Cr of operating cash against ₹4,086 Cr of profit. After ₹11,899 Cr of capital spending, ₹−615 Cr was left as free cash.
FY26: operating cash of ₹11,284 Cr against reported profit of ₹4,086 Cr, leaving free cash of ₹−615 Cr after ₹11,899 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 223% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 223%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: the bigger cash user is investment — capital spending ran 2.3× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Samvardhana Motherson International Ltd's cash conversion cycle runs −26 days in FY26, up from −29 days in FY21. Capital spending ran ₹31,404 Cr over the last 3 years. At FY26 sales of ₹1,26,104 Cr each day of that cycle holds about ₹345 Cr, so roughly ₹−8,983 Cr sits inside the business at any moment.
FY26: debtors at 58 days, inventory at 68 days — roughly 2.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −26 days, looser than FY21's −29.
The full loop: cash goes out to suppliers and production on day 0; stock waits 68 days to sell; customers pay about 58 days after that; and suppliers themselves are paid at 152 days — netting out to the −26-day cycle.
In money terms: at FY26 sales of ₹1,26,104 Cr, each day of the cycle holds about ₹345 Cr — so the −26-day loop keeps roughly ₹−8,983 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹31,404 Cr over the last 3 fiscal years against ₹13,437 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹4,094 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Samvardhana Motherson International Ltd earns a ROCE of 13% in FY26. That is up from a trough of 6% in FY21. Return on invested capital clears the cost of that capital by −2.2 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 3.2% net margin on 1.15× asset turns.
FY26 ROCE is 13%, recovered from a FY21 trough of 6% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 3.2% net margin × 1.15× asset turns × 2.67× balance-sheet leverage ≈ 9.8% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 9.8% − 12.0% = a −2.2 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Samvardhana Motherson International Ltd carries total debt of ₹19,170 Cr against shareholder equity of ₹43,659 Cr as of Jun 26, a debt-to-equity of 0.44. On the annual view that ratio went from 0.63 in FY22 to 0.44 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Why this happened. Motherson operationalized 3 facilities in Q1 FY27, supporting future revenue streams. Of the 16 facilities globally under development, 10 of 13 are expected operational in FY27. Total group capex Rs 6000 Cr FY27 guidance with Q1 FY27 Rs 1514 Cr (52% of EBITDA) tracking to plan. CWIP rose from Rs 1310 Cr (Mar-22) to Rs 4094 Cr (Mar-26) before greenfields began commissioning. As each facility ramps, fixed-cost absorption improves and ROCE converges toward the 40% group target. Leverage at 0.8x provides headroom to complete the build without financial stress.
Jun 26: total debt of ₹19,170 Cr against shareholder equity of ₹43,659 Cr — a debt-to-equity of 0.44. On the annual view, debt-to-equity went from 0.63 (FY22) to 0.44 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 11.8 points of Samvardhana Motherson International Ltd over 8 quarters, the biggest move on the register. That takes promoters to 48.6% of the company. Domestic institutions moved +2.6 points over the same window, to 20.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −11.8 points over 8 quarters to 48.6%; Domestic institutions: +2.6 points over 8 quarters to 20.6%; Foreign institutions: +0.0 points over 8 quarters to 12.9%.
🚨 Why the register moved: promoters drove it (−11.8 points), absorbed on the other side by domestic institutions (+2.6 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Samvardhana Motherson International Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Samvardhana Motherson International Ltd trades at 38.0× P/E, mid-range by its own standards (67th percentile). Its long-run median P/E is 32.8×, measured across 10.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 38.0× is mid-range by its own standards (67th percentile), against a long-run median of 32.8× measured over 10.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved +1.7% against a +57.1% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +16.3%/yr price move, ~+7.3%/yr came from earnings growth and ~+9.0 pp from the multiple (expanding); over 10y, of the +11.9%/yr price move, ~+8.1%/yr came from earnings growth and ~+3.8 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 24 August 2026 price, Samvardhana Motherson International Ltd was paying for profit growth of about 23.8% a year. Profit itself has compounded 8.7% a year over the past 10 years. Today the market pays 38.0× P/E, the 67th percentile of its own 11-year range.
What the two numbers say together. The multiple is full against its own past, and the growth the price is paying for is far above what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 24 August 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Samvardhana Motherson International Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −13.9% at the trough to +24.7%, a 2-quarter improving streak, ROCE lifting at 14.2%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +10.9% | +17.0% | +17.1% | +13.0% |
| Profit | −1.4% | +34.7% | +21.1% | +8.7% |
| EPS | +1.7% | +35.5% | +20.2% | +6.6% |
| Share price | +57.1% | +35.3% | +16.3% | +11.9% |
4-Factor Sector Score
49.0/100 — rank 12 of 20 in Auto Ancillaries - Diversified · 100% evidence confidence
Samvardhana Motherson International Ltd scores 49.0 out of 100 against the 20 companies it is compared with in Auto Ancillaries - Diversified, ranking 12. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 20.3 + 8.7 + 4.8 + 15.2 = 49. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Said versus delivered
What Samvardhana Motherson International Ltd's management promised, set against what actually arrived — 4 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.
Consumer Electronics Order Visibility Became Unclear · 6 August 2026. In May 2026, management said the upcoming consumer electronics plant was fully spoken for, implying strong order coverage for the planned ramp. In Aug 2026, management said orders were still under negotiation without clarifying whether these were incremental orders beyond the previously committed load, creating a materially different visibility profile for the plant's revenue ramp and valuation.
Booked Business Deviation · 20 May 2026. In the Nov 2025 call, management stated that the booked business of the company stood at USD 87.2 billion. However, in the May 2026 call, management claimed that a booked business of USD 76 billion represented an all-time high, creating a major contradiction with the previously reported larger figure.\nPrior Call (Nov 2025): Further, our book business stands at $87.2 billion as of September 2025.\nLatest Call (May 2026): Another major highlight for the year was our all-time high booked business of US$ 76 billion.
Vision 2030 Revenue Target Contradiction · 20 May 2026. In both the Nov 2025 and Feb 2026 calls, management repeatedly referenced a USD 108 billion gross revenue target for Vision 2030. However, in the prepared remarks of the latest May 2026 call, management stated that the Vision 2030 aspiration is USD 36 billion in gross revenues, presenting a significant reduction that contradicts the previously stated goal.\nPrior Call 1 (Feb 2026): great financial year, first financial year for our 108 target.\nPrior Call 2 (Nov 2025): going from 27 to 108, that's a lot of growth.\nLatest Call (May 2026): We continue to move steadily towards our Vision 2030 aspiration of USD 36 billion in gross revenues...
Leverage Reduction Target Omission · 10 February 2026. In the November 2025 call, management provided explicit guidance that the net debt-to-EBITDA ratio would decrease to approximately 0.9x by the end of the 2026 fiscal year. However, during the February 2026 call, management reported leverage remained stagnant at 1.1x and described this level as comfortable without acknowledging the previously targeted reduction for the year-end. Earlier call (Nov 2025): “We expect the leverage ratio to be around 0.9 by the end of the year, contributed by improvement in the business profile, better free cash flows and reduction on the working capital front.” Later call (Feb 2026): “Our leverage ratio remains comfortable at 1.1 times net debt to NKM EBITDA, providing us with the financial strength and flexibility to pursue our 2030 targets.”
Every quote above is taken word for word from the company’s own earnings calls.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Lumax Auto Technologies LtdLUMAXTECH | 77.7/100Favorable setup100% evidence | BREAKING OUT | 31.2/35 Revenue 33.3% · PAT 58.3% · OPM change 2 pp 100% evidence | 17.9/25 ROCE 21.2% · OPM 14% 100% evidence | 11.6/20 P/E 41× · PEG 0.75 100% evidence | 17.0/20 RS sector 7.7% · RS bench 29.4% · 1Y 86.6%5 of 12 weeks ahead 100% evidence |
| Exact sum: 31.2 + 17.9 + 11.6 + 17 = 77.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2S J S Enterprises LtdSJS | 72.1/100Favorable setup100% evidence | LEADER | 29.6/35 Revenue 28.6% · PAT 67.5% · OPM change 2 pp 100% evidence | 20.4/25 ROCE 28.6% · OPM 29% 100% evidence | 10.1/20 P/E 39.8× · PEG 0.89 100% evidence | 12.0/20 RS sector 6.9% · RS bench 27.6% · 1Y 67.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 29.6 + 20.4 + 10.1 + 12 = 72.1 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3OBSC Perfection LtdOBSCP | 66.2/100Favorable setup80% evidence | LEADER | 21.9/35 Revenue 37.8% · PAT 46.2% · OPM change 0 pp 95% evidence | 15.6/25 ROCE 19.5% · OPM 17.9% 95% evidence | 8.7/20 P/E 78.8× · PEG — 15% evidence | 20.0/20 RS sector 93.6% · RS bench 126% · 1Y 185.3%12 of 12 weeks ahead 100% evidence |
| Exact sum: 21.9 + 15.6 + 8.7 + 20 = 66.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Sansera Engineering LtdSANSERA | 64.4/100Mixed-positive evidence100% evidence | LEADER | 26.6/35 Revenue 23.5% · PAT 52.2% · OPM change 2 pp 100% evidence | 12.0/25 ROCE 14.5% · OPM 19% 100% evidence | 7.2/20 P/E 69.2× · PEG 1.28 100% evidence | 18.6/20 RS sector 49% · RS bench 75.4% · 1Y 202.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26.6 + 12 + 7.2 + 18.6 = 64.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Carraro India LtdCARRARO | 59.7/100Mixed-positive evidence93% evidence | TURNING | 23.7/35 Revenue 26.3% · PAT 47.8% · OPM change -2 pp 100% evidence | 15.8/25 ROCE 29.3% · OPM 8% 100% evidence | 15.9/20 P/E 21.9× · PEG 0.42 65% evidence | 4.3/20 RS sector -14.1% · RS bench 3.7% · 1Y 24.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 23.7 + 15.8 + 15.9 + 4.3 = 59.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -14.1% and the one-year return is 24.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 6Automobile Corporation Of Goa LtdACGL | 57.1/100Mixed-positive evidence76% evidence | 20.6/35 Revenue 29.7% · PAT 11.5% · OPM change -6 pp 95% evidence | 16.6/25 ROCE 29.6% · OPM 5% 76% evidence | 13.0/20 P/E 18× · PEG — 50% evidence | 6.9/20 RS sector -8.3% · RS bench -3.6% · 1Y -15.3%0 of 12 weeks ahead 70% evidence | |
| Exact sum: 20.6 + 16.6 + 13 + 6.9 = 57.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Bosch LtdBOSCHLTD | 56.8/100Mixed-positive evidence82% evidence | LEADER | 15.9/35 Revenue 13.6% · PAT -11.4% · OPM change 1 pp 95% evidence | 17.6/25 ROCE 21.5% · OPM 14% 76% evidence | 6.3/20 P/E 60.4× · PEG — 50% evidence | 17.0/20 RS sector 6.7% · RS bench 28.1% · 1Y 18.3%12 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 17.6 + 6.3 + 17 = 56.8 · Decision use: Price leads the evidence: RS versus the benchmark is 28.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 8Jay Bharat Maruti LtdJAYBARMARU | 56.6/100Mixed-positive evidence87% evidence | FADING | 23.1/35 Revenue 13.3% · PAT 100% · OPM change -2 pp 95% evidence | 13.1/25 ROCE 16.6% · OPM 10% 95% evidence | 14.8/20 P/E 9.1× · PEG — 50% evidence | 5.6/20 RS sector -9.2% · RS bench 7.8% · 1Y 19.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 23.1 + 13.1 + 14.8 + 5.6 = 56.6 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -9.2% and the one-year return is 19.5%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 9Minda Corporation LtdMINDACORP | 56.5/100Mixed-positive evidence94% evidence | BREAKING OUT | 26.3/35 Revenue 26.6% · PAT 94.9% · OPM change 0 pp 100% evidence | 8.8/25 ROCE 12.7% · OPM 11% 100% evidence | 8.7/20 P/E 41.8× · PEG 1.58 100% evidence | 12.7/20 RS sector 1.7% · RS bench 19.5% · 1Y 40%11 of 11 weeks ahead 70% evidence |
| Exact sum: 26.3 + 8.8 + 8.7 + 12.7 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Suprajit Engineering LtdSUPRAJIT | 51.3/100Mixed-positive evidence94% evidence | TURNING | 25.0/35 Revenue 18.4% · PAT 73.2% · OPM change 3 pp 100% evidence | 10.0/25 ROCE 15.5% · OPM 12% 100% evidence | 5.8/20 P/E 35.7× · PEG 5.51 100% evidence | 10.5/20 RS sector -2.5% · RS bench 8.3% · 1Y 6.1%9 of 11 weeks ahead 70% evidence |
| Exact sum: 25 + 10 + 5.8 + 10.5 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Varroc Engineering LtdVARROC | 50.5/100Mixed-positive evidence87% evidence | BREAKING OUT | 16.6/35 Revenue 14.7% · PAT 39.9% · OPM change -2 pp 100% evidence | 9.6/25 ROCE 19% · OPM 8% 100% evidence | 13.9/20 P/E 46.7× · PEG 0.63 65% evidence | 10.4/20 RS sector -8.5% · RS bench 43.4% · 1Y 44.8%11 of 11 weeks ahead 70% evidence |
| Exact sum: 16.6 + 9.6 + 13.9 + 10.4 = 50.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Samvardhana Motherson International Ltdthis pageMOTHERSON | 49.0/100Mixed-negative evidence100% evidence | LEADER | 20.3/35 Revenue 14% · PAT 24.7% · OPM change 1 pp 100% evidence | 8.7/25 ROCE 13.4% · OPM 9% 100% evidence | 4.8/20 P/E 38× · PEG 5.68 100% evidence | 15.2/20 RS sector 8.7% · RS bench 29.9% · 1Y 73.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20.3 + 8.7 + 4.8 + 15.2 = 49 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Endurance Technologies LtdENDURANCE | 46.4/100Mixed-negative evidence100% evidence | BREAKING OUT | 17.1/35 Revenue 29.4% · PAT 13.1% · OPM change -1 pp 100% evidence | 12.8/25 ROCE 17.8% · OPM 12% 100% evidence | 9.0/20 P/E 38.5× · PEG 2.33 100% evidence | 7.5/20 RS sector -14% · RS bench 3.7% · 1Y -9.3%11 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 12.8 + 9 + 7.5 = 46.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Sharda Motor Industries LtdSHARDAMOTR | 46.3/100Mixed-negative evidence100% evidence | TURNING | 9.0/35 Revenue 25.6% · PAT -1.8% · OPM change -3 pp 100% evidence | 17.4/25 ROCE 34.5% · OPM 10% 100% evidence | 9.6/20 P/E 16.2× · PEG 2.75 100% evidence | 10.3/20 RS sector -13% · RS bench 5.4% · 1Y -10.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 9 + 17.4 + 9.6 + 10.3 = 46.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15NDR Auto Components LtdNDRAUTO | 44.7/100Mixed-negative evidence87% evidence | ASLEEP | 17.1/35 Revenue 18.2% · PAT 16.4% · OPM change 0 pp 95% evidence | 16.0/25 ROCE 22.2% · OPM 11% 95% evidence | 9.9/20 P/E 25.2× · PEG — 50% evidence | 1.7/20 RS sector -28.4% · RS bench -13.4% · 1Y -38.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 16 + 9.9 + 1.7 = 44.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Munjal Auto Industries LtdMUNJALAU | 42.1/100Mixed-negative evidence87% evidence | LEADER | 15.0/35 Revenue 22.3% · PAT 19.1% · OPM change 0 pp 95% evidence | 6.6/25 ROCE 9.8% · OPM 6% 95% evidence | 9.1/20 P/E 20.8× · PEG — 50% evidence | 11.4/20 RS sector 1% · RS bench 20.9% · 1Y 20.2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 15 + 6.6 + 9.1 + 11.4 = 42.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17ZF Commercial Vehicle Control System India LtdZFCVINDIA | 39.4/100Mixed-negative evidence100% evidence | BREAKING OUT | 10.8/35 Revenue 9% · PAT 3.1% · OPM change 0 pp 100% evidence | 14.4/25 ROCE 19.4% · OPM 13% 100% evidence | 7.5/20 P/E 57.4× · PEG 4.2 100% evidence | 6.7/20 RS sector -10.7% · RS bench 7.8% · 1Y 13%2 of 12 weeks ahead 100% evidence |
| Exact sum: 10.8 + 14.4 + 7.5 + 6.7 = 39.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Motherson Sumi Wiring India LtdMSUMI | 38.3/100Mixed-negative evidence100% evidence | BASING | 11.3/35 Revenue 28.7% · PAT 4.3% · OPM change -2 pp 100% evidence | 17.1/25 ROCE 38.9% · OPM 8% 100% evidence | 7.7/20 P/E 38.4× · PEG 6.28 100% evidence | 2.2/20 RS sector -28.5% · RS bench -13.1% · 1Y -19.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 11.3 + 17.1 + 7.7 + 2.2 = 38.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Mercury EV-Tech LtdMERCURYEV | 28.2/100Adverse evidence74% evidence | BREAKING OUT | 8.4/35 Revenue 4.2% · PAT -47.6% · OPM change 0.4 pp 95% evidence | 4.8/25 ROCE 2.6% · OPM 9.8% 95% evidence | 8.5/20 P/E 174× · PEG — 15% evidence | 6.5/20 RS sector -39% · RS bench 15.8% · 1Y -18.9%7 of 9 weeks ahead 70% evidence |
| Exact sum: 8.4 + 4.8 + 8.5 + 6.5 = 28.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Precision Camshafts LtdPRECAM | 26.6/100Adverse evidence81% evidence | ASLEEP | 5.9/35 Revenue -4.9% · PAT -33.3% · OPM change -3.6 pp 95% evidence | 6.5/25 ROCE 7.3% · OPM 3.8% 95% evidence | 10.9/20 P/E 35.2× · PEG — 50% evidence | 3.3/20 RS sector -32% · RS bench -23.2% · 1Y -36.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 5.9 + 6.5 + 10.9 + 3.3 = 26.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Samvardhana Motherson International Ltd's share price today?
Samvardhana Motherson International Ltd trades at ₹164, +57.1% over the past year. The company is valued at ₹1,73,568 Cr. The stock sits at 92% of its 52-week range of ₹104–₹169, +20.3% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 49 weeks in. — as of 11 September 2026.
What were Samvardhana Motherson International Ltd's latest quarterly results?
Samvardhana Motherson International Ltd reported revenue of ₹35,244 Cr and net profit of ₹1,076 Cr for the Jun 26 quarter. Revenue rose 16.7% and profit rose 77.6% year on year. Earnings per share were ₹0.98. The operating margin was 9.0%, 1.0 pp higher than a year earlier. — as of 11 September 2026.
What is Samvardhana Motherson International Ltd's revenue?
Samvardhana Motherson International Ltd reported revenue of ₹35,244 Cr in the Jun 26 quarter, +16.7% year on year. For the full FY26 fiscal year, revenue was ₹1,26,104 Cr (+10.9%). Over the last 10 years revenue compounded at 13.0% a year. — as of 11 September 2026.
What is Samvardhana Motherson International Ltd's profit?
Samvardhana Motherson International Ltd earned ₹1,076 Cr of net profit in the Jun 26 quarter, +77.6% year on year — the 3rd straight quarter of growth. Full-year FY26 profit was ₹4,086 Cr. The operating margin ran 9.0% in the latest quarter. — as of 11 September 2026.
What is Samvardhana Motherson International Ltd's market cap?
Samvardhana Motherson International Ltd's market capitalisation is ₹1,73,568 Cr at a share price of ₹164. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Samvardhana Motherson International Ltd's P/E ratio?
Samvardhana Motherson International Ltd trades at a P/E of 38.0×, at the 67th percentile of its own 11-year range, against a long-run median of 32.8×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Samvardhana Motherson International Ltd pay a dividend?
Yes — Samvardhana Motherson International Ltd's dividend payout was 16% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Samvardhana Motherson International Ltd overvalued?
On its own history, Samvardhana Motherson International Ltd looks expensive: its P/E of 38.0× sits at the 67th percentile of its 11-year range (long-run median 32.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 11 September 2026.
Is Samvardhana Motherson International Ltd growing?
Yes — Samvardhana Motherson International Ltd is growing: latest-quarter revenue +16.7% year on year, profit +77.6%, and the margin +1.0 pp at 9.0%. The 10-year compound rates are 13.0% (revenue) and 8.7% (profit). The earnings engine currently reads: improving — as of 11 September 2026.
How is Samvardhana Motherson International Ltd performing?
Samvardhana Motherson International Ltd is in a confirmed uptrend, 49 weeks in. Its latest quarter's revenue rose 16.7% and profit rose 77.6% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Samvardhana Motherson International Ltd in?
Turning around — profit growth swung from −13.9% at the trough to +24.7%, a 2-quarter improving streak, ROCE lifting at 14.2%. The read comes from the last 12 quarters of growth (revenue growth +14.0% latest, profit growth +24.7% latest, eps growth +32.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Samvardhana Motherson International Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 49 of stage 2), trading +20.3% versus its 200-day average and at 92% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Samvardhana Motherson International Ltd beating the market?
On recent form, yes — Samvardhana Motherson International Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 7 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +361% against the NIFTY 500's +273% — ahead of the index over the full window. — as of 11 September 2026.
Will Samvardhana Motherson International Ltd's share price go up?
This page publishes no price forecast for Samvardhana Motherson International Ltd. What it measures instead: the share price is ₹164, the price is in a confirmed uptrend 49 weeks in. Its P/E of 38.0× sits at the 67th percentile of its own 11-year range. — as of 11 September 2026.
Who owns Samvardhana Motherson International Ltd?
Promoters hold 48.6% of Samvardhana Motherson International Ltd, foreign institutions 12.9%, domestic institutions 20.6% and the public 17.7% (latest quarter). The biggest move on the register over the last two years: Promoters cut 11.8 points over 8 quarters. — as of 11 September 2026.
Does Samvardhana Motherson International Ltd have too much debt?
It is moderate — Samvardhana Motherson International Ltd's debt-to-equity is 0.47, and operating profit covers the interest bill 8×. FY26 borrowings were ₹19,170 Cr against equity of ₹40,979 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Samvardhana Motherson International Ltd's capex?
Samvardhana Motherson International Ltd spent ₹31,404 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹11,899 Cr, with ₹4,094 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Samvardhana Motherson International Ltd's cash flow?
Samvardhana Motherson International Ltd generated ₹11,284 Cr of operating cash flow in FY26 and ₹−615 Cr of free cash flow after ₹11,899 Cr of capital spending. Reported profit that year was ₹4,086 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Samvardhana Motherson International Ltd's profit real cash?
Yes — over the last 3 fiscal years, 223% of Samvardhana Motherson International Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹11,284 Cr against reported profit of ₹4,086 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Samvardhana Motherson International Ltd in its business cycle?
Samvardhana Motherson International Ltd's FY26 operating margin was 10.0%, against a 13-year band of 7.0%–10.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 9.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Samvardhana Motherson International Ltd's price assume?
At its price on 24 August 2026, Samvardhana Motherson International Ltd was priced for profit growth of about 23.8% a year. Profit itself has compounded 8.7% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Samvardhana Motherson International Ltd story?
The sharpest disagreement: the price moved +57.1% in a year while annual EPS moved +1.7% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Samvardhana Motherson International Ltd a stock worth studying right now?
This is not investment advice. The machine read: Samvardhana Motherson International Ltd's price has outrun its earnings. +57.1% in a year against EPS +1.7% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!